Exosens (LON: 0EXO)
London flag London · Delayed Price · Currency is GBP · Price in EUR
21.02
+0.28 (1.37%)
At close: Jan 22, 2025

Exosens Statistics

Total Valuation

Exosens has a market cap or net worth of GBP 891.14 million. The enterprise value is 1.01 billion.

Market Cap 891.14M
Enterprise Value 1.01B

Important Dates

The next estimated earnings date is Monday, March 3, 2025.

Earnings Date Mar 3, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 27.50M

Valuation Ratios

The trailing PE ratio is 537.92.

PE Ratio 537.92
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio 118.10
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.24, with an EV/FCF ratio of 27.36.

EV / Earnings 608.06
EV / Sales 3.37
EV / EBITDA 13.24
EV / EBIT 18.57
EV / FCF 27.36

Financial Position

The company has a current ratio of 2.83, with a Debt / Equity ratio of 0.68.

Current Ratio 2.83
Quick Ratio 1.64
Debt / Equity 0.68
Debt / EBITDA 2.90
Debt / FCF 6.00
Interest Coverage 1.49

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Capital (ROIC) n/a
Revenue Per Employee 187,431
Profits Per Employee 1,035
Employee Count 1,232
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 19.64
200-Day Moving Average n/a
Relative Strength Index (RSI) 56.86
Average Volume (20 Days) 3,445

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Exosens had revenue of GBP 299.89 million and earned 1.66 million in profits.

Revenue 299.89M
Gross Profit 171.26M
Operating Income 54.38M
Pretax Income 13.17M
Net Income 1.66M
EBITDA 74.13M
EBIT 54.38M
Earnings Per Share (EPS) n/a
Full Income Statement

Balance Sheet

The company has 104.45 million in cash and 220.94 million in debt, giving a net cash position of -116.49 million.

Cash & Cash Equivalents 104.45M
Total Debt 220.94M
Net Cash -116.49M
Net Cash Per Share n/a
Equity (Book Value) 323.87M
Book Value Per Share n/a
Working Capital 173.12M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 63.05 million and capital expenditures -26.23 million, giving a free cash flow of 36.82 million.

Operating Cash Flow 63.05M
Capital Expenditures -26.23M
Free Cash Flow 36.82M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 57.11%, with operating and profit margins of 18.13% and 3.68%.

Gross Margin 57.11%
Operating Margin 18.13%
Pretax Margin 4.39%
Profit Margin 3.68%
EBITDA Margin 24.72%
EBIT Margin 18.13%
FCF Margin 12.28%

Dividends & Yields

Exosens does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield 0.19%
FCF Yield 4.13%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Exosens has an Altman Z-Score of 2.69. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.69
Piotroski F-Score n/a